Historical record - last NADAC effective date: 6/23/2021
Product Information
ANTI-DIARRHEAL 2 MG TABLET is a generic product labeled by Topco Associates LLC, priced at $0.1270 per EA under NDC 36800022453. Its NADAC has been published 397 times since Nov 28, 2013.
FDA first approved this application on Jan 6, 2000.
Strength
2 mg/1
Manufacturer
Topco Associates LLCNDC
36800022453
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075232FDA Approved
1/6/2000
On Market Since
2/26/2003
Pharmacological Classes
Price Statistics
The NADAC for ANTI-DIARRHEAL 2 MG TABLET has been published 397 times since Nov 28, 2013, and over the history we have for it it has risen 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1270 per EA |
|---|---|
| All-time high | $0.1351 (Dec 16, 2020) |
| All-time low | $0.1021 (Oct 21, 2015) |
| Median price | $0.1141 |
| Average price | $0.1145 |
| Largest weekly change | +14.6% (Jan 22, 2014) |
| Weeks tracked | 397 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+17.7%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loperamide Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANTI-DIARRHEAL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ANTI-DIARRHEAL 2 MG TABLET, manufactured by Topco Associates LLC, is $0.1270 per EA (NDC 36800022453), effective Jun 30, 2021.
How has the price of ANTI-DIARRHEAL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ANTI-DIARRHEAL 2 MG TABLET has risen 17.7%. It has been tracked across 397 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ANTI-DIARRHEAL 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ANTI-DIARRHEAL 2 MG TABLET has ranged from a low of $0.1021 (Oct 21, 2015) to a high of $0.1351 (Dec 16, 2020), with a median of $0.1141 per EA.
Are there cheaper alternatives to ANTI-DIARRHEAL 2 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ANTI-DIARRHEAL 2 MG CAPLET, is $0.1204 per EA — about 5% below ANTI-DIARRHEAL 2 MG TABLET.
Who manufactures ANTI-DIARRHEAL 2 MG TABLET?
ANTI-DIARRHEAL 2 MG TABLET (NDC 36800022453) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.